HDAC5 and lung cancer: Relating to the mechanisms of LMK-235’s cytotoxic action, studies performed on lung cancer cells indicate that HDAC5 inhibition with LMK-235 interferes with the ERK-1/2 pathway involved in the differentiation of cancer stem cells [32].